Australia’s regulator is expediting an application to vary the approval of Pfizer’s vaccine to include teens aged between 12 and 15.
The Therapeutic Goods Administration has already approved the Pfizer jab from the age of 16. Many experts predict younger teens will inevitably be part of the vaccine rollout as the highly contagious delta variant of the virus has changed the risk equation and vaccination is the only way out of the current crisis.
Loading...
Jill Margo is based in the Sydney office. Jill has won multiple prizes, including two Walkley Awards and is an adjunct associate professor at School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Australia. Connect with Jill on Twitter. Email Jill at jmargo@afr.com
Tom McIlroy is the Financial Review’s Canberra bureau chief based in the press gallery at Parliament House. He was previously the AFR’s political correspondent. Connect with Tom on Twitter. Email Tom at thomas.mcilroy@afr.com
